PUBLISHER: The Business Research Company | PRODUCT CODE: 1948339
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948339
Thrombectomy devices are utilized for vacuum aspiration to eliminate occlusive clots in acute ischemic stroke. Surgical thrombectomy involves the extraction or suctioning out of the clot using a specially designed clot removal device introduced through a catheter, aiming to restore blood flow.
The primary types of thrombectomy devices include aspiration thrombectomy devices, mechanical thrombectomy devices, ultrasonic thrombectomy devices, and others. Aspiration thrombectomy devices are medical instruments designed for the removal of blood clots or thrombi from blood vessels. These devices find application in various areas such as cardiovascular, peripheral, and neurovascular applications, and are utilized by entities such as hospitals, surgical centers, ambulatory care facilities, academia, and contract research organizations (CROs).
Tariffs are impacting the thrombectomy devices market by increasing costs of imported precision catheters, nitinol components, imaging-compatible materials, and advanced manufacturing equipment used in aspiration and mechanical thrombectomy systems. Hospitals and stroke centers in North America and Europe are most affected due to reliance on specialized imported devices, while Asia-Pacific faces cost pressures in device manufacturing and distribution. These tariffs are increasing procedural costs and procurement expenses. However, they are also encouraging localized device manufacturing, regional supplier partnerships, and innovation in cost-efficient thrombectomy technologies.
The thrombectomy devices market research report is one of a series of new reports from The Business Research Company that provides thrombectomy devices market statistics, including thrombectomy devices industry global market size, regional shares, competitors with a thrombectomy devices market share, detailed thrombectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the thrombectomy devices industry. This thrombectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thrombectomy devices market size has grown strongly in recent years. It will grow from $1.64 billion in 2025 to $1.78 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising incidence of ischemic stroke cases, increasing availability of specialized stroke centers, improvements in catheter-based intervention techniques, growing clinician awareness of thrombectomy benefits, expansion of neurointerventional training programs.
The thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of thrombectomy in wider patient populations, growing demand for faster reperfusion outcomes, expansion of advanced neurovascular infrastructure, rising investments in next-generation thrombectomy devices, increasing focus on combination therapy approaches. Major trends in the forecast period include increasing adoption of aspiration-based thrombectomy techniques, rising use of stent retriever devices, growing focus on rapid stroke intervention protocols, expansion of minimally invasive neurovascular procedures, enhanced device precision and trackability.
The growing aging population is expected to drive the growth of the thrombectomy devices market in the coming years. An aging population refers to a demographic trend marked by an increasing proportion of elderly individuals within a society over time. Thrombectomy devices are essential for managing health conditions common in the aging population, including stroke, coronary artery disease, aortic thrombosis, and deep vein thrombosis (DVT). For example, in October 2025, the World Health Organization (WHO), a Switzerland-based UN agency, projected that by 2030, one in six people globally will be aged 60 or older, with this population expected to double to 2.1 billion by 2050. Thus, the growing aging population is fueling growth in the thrombectomy devices market.
Major players in the thrombectomy devices market are dedicated to creating innovative solutions, such as arterial thrombectomy systems. An arterial thrombectomy system is a medical device specifically crafted for removing blood clots (thrombi) from arteries. For instance, in June 2023, Penumbra, Inc., a US-based healthcare company, unveiled the 'Lightning Bolt 7,' a new arterial thrombectomy system designed for efficient blood clot removal from arteries. The system incorporates pressure sensors paired with an algorithm, facilitating the removal of large and fibrous blood clots from arteries with minimal blood loss. It is employed to address conditions where a blockage hinders blood flow to organs such as the intestines, spleen, limbs, and liver. The integration of computer-aided components not only enhances safety but also encourages a preference for an endovascular-first approach in a broader range of cases, prioritizing it over open surgery.
In May 2024, GTCR, a private equity firm based in the U.S., acquired Surmodics for an undisclosed amount. This acquisition is intended to bolster Surmodics' growth, support its innovation in medical technologies, enhance shareholder value, and utilize synergies to expand its market presence, while transitioning the company to a private structure for a more strategic focus. Surmodics specializes in drug delivery technologies, in vitro diagnostic (IVD) products, medical device coatings, and thrombectomy devices.
Major companies operating in the thrombectomy devices market are Stryker Corporation, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Penumbra Inc., Abbott Laboratories, Inari Medical Inc., BTG International Ltd., Phenox GmbH, Acandis GmbH & Co. KG, Straub Medical AG, MicroVention Inc., Rapid Medical, Neuravi Limited, Arteria Therapeutics Inc., Johnson and Johnson, Edwards Lifesciences Corporation, Argon Medical Devices Inc., Teleflex Incorporated, AngioDynamics, Koninklijke Philips NV, Spectranetics Corporation, C. R. Bard Inc., Walk Vascular LLC, Kaneka Corporation, Baxter International
North America was the largest region in the thrombectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global thrombectomy devices market report during the forecast period. The regions covered in the thrombectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the thrombectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The thrombectomy devices market consists of sales of mechanical thrombectomy, and aspiration thrombectomy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Thrombectomy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses thrombectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for thrombectomy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thrombectomy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.